Effectiveness, safety, and composite clinical outcomes between apixaban and other oral anticoagulants for non-valvular atrial fibrillation patients in the US Medicare population

27 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation - Stroke prevention 1 Oral Anticoagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo

Bristol-Myers Squibb, Lawrenceville (United States of America)

9 More presentations in this session

Presentation thumbnail
Associate Professor Y. Baek (Incheon, KR)
Presentation thumbnail
Doctor H. Zulkifly (Selangor, MY)
Presentation thumbnail
Associate Professor B. Hudzik (Zabrze, PL)
Presentation thumbnail
Doctor D. Kim (Seoul, KR)
Presentation thumbnail
Mr M. Christensen (Copenhagen, DK)

The Event

Event poster

ESC Congress 2018

27 August 2018 14:00 CET

ESC 365 is supported by

ESC 365 is supported by